| Identification | Back Directory | [Name]
Pentanoic acid, 5-[[2-(1H-imidazol-4-yl)ethyl]amino]-5-oxo- | [CAS]
219694-63-0 | [Synonyms]
Ingavirin
Ingavirin-D6
4-{[2-(1H-imidazol-5-yl)ethyl]carbamoyl}butanoic acid
Pentanoic acid, 5-[[2-(1H-imidazol-4-yl)ethyl]amino]-5-oxo-
Pentanoic acid, 5-[[2-(1H-imidazol-5-yl)ethyl]amino]-5-oxo- | [Molecular Formula]
C10H15N3O3 | [MDL Number]
MFCD07534923 | [MOL File]
219694-63-0.mol | [Molecular Weight]
225.24 |
| Chemical Properties | Back Directory | [InChI]
InChI=1S/C10H15N3O3/c14-9(2-1-3-10(15)16)12-5-4-8-6-11-7-13-8/h6-7H,1-5H2,(H,11,13)(H,12,14)(H,15,16) | [InChIKey]
KZIMLUFVKJLCCH-UHFFFAOYSA-N | [SMILES]
C(O)(=O)CCCC(NCCC1NC=NC=1)=O |
| Hazard Information | Back Directory | [Uses]
Ingavirin (Ingamine) exhibits broad spectrum antiviral activities against human respiratory viruses, such as influenza virus A (IVA), human parainfluenza virus (hPIV) and human adenovirus (AdV). Ingavirin exhibits no toxixcity to mice at the dose of 3000 mg/kg[1]. | [References]
[1] Zarubaev VV, et al., Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments. Pharmaceuticals (Basel). 2011 Nov 25;4(12):1518-1534. DOI:10.3390/ph4121518 |
|
|